Molecular testing stratifies the risk of structural recurrence in high risk differentiated thyroid cancer: a retrospective cohort study.

Front Endocrinol (Lausanne) · 2025 · PMC11802368 · PMID 39926346

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

did not reach statistical significancep = 0.075so close (0.05 < p ≤ 0.1)

Among these, 13 cases (76.5%) in the HMR group and 3 cases (37.5%) in the non-HMR group met RAI refractory criteria, although this difference did not reach statistical significance ( p = 0.075).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.